$RNGR

Ranger Energy Services, Inc. (RNGR): Results of Operations and Financial Condition

Ranger Energy Services, Inc. (RNGR) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 rngr-063026ex991earningsre.htm EX-99.1 Document EXHIBIT 99.1 Ranger Energy Services, Inc. Reports Second Quarter 2026 Financial Results HOUSTON, TX — (July 27, 2026) — Ranger Energy Services, Inc. (NYSE: RNGR) (“Ranger” or the “Company”) today reported its financial and

Original reporting
Published Jul 27, 2026, 9:24 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 27, 2026, 9:27 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$RNGR
Bullish
medium confidence
Mentioned
$RNGR
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$RNGRBullishMed
01

Why it matters

Traders can update RNGR’s near-term earnings and cash-flow expectations based on the reported Q2 revenue, net income, Adjusted EBITDA and margin, and Free Cash Flow, while also incorporating management’s stated 2H 2026 Wireline activity reduction risk.

02

Market read

The filing is a primary-source earnings release with specific quarterly numbers and shareholder return actions, making it actionable for RNGR positioning.

03

What to watch

Segment margin headwinds included a state sales tax audit and make-ready costs for upcoming ECHO deployments, which may recur or signal cost volatility.

Relevance 7/10Novelty 7/10Timing: after-hours, following the Q2 2026 results 8-K

Background

The 8-K (Item 2.02) includes Exhibit 99.1 with Ranger’s Q2 2026 financial and operational highlights, management commentary, capital returns update, and performance summary.

Company-level read

Ticker impact

$RNGRBullishMedium confidence
Context

Ranger reported Q2 2026 revenue of $176.5M, net income of $6.9M, and Adjusted EBITDA of $28.6M, plus a $0.06 quarterly dividend.

Expected impact

Likely modest positive reaction versus prior expectations, with follow-through tied to whether the company sustains EBITDA margin and cash flow into 2H 2026.

Evidence & confidence

The filing provides concrete quarterly datapoints (revenue, net income, Adjusted EBITDA, FCF) and capital return actions (buybacks and a declared dividend). However, it also flags expected back-half activity reductions in Wireline, which can cap upside.

Market effects

Provides a read-through on US energy services demand and utilization trends across segments (High Specification Rigs, AWS-related ancillary services, Wireline).

Primarily US-focused activity commentary, with no explicit regional macro shock described.

Limited direct global linkage; impacts are mostly tied to US energy resource demand and customer activity levels.

Counterpoint

Despite strong Q2 metrics, management expects Wireline activity and profitability to soften in the back half of 2026, which could reduce forward multiple support.

Key entities

  • Ranger Energy Services, Inc.

    Reported Q2 2026 results, segment performance commentary, and capital return actions including buybacks and a declared quarterly dividend.

  • ECHO Hybrid Electric Rig fleet

    Management highlighted ongoing build-out and interest for additional deployments, including an award for three additional ECHO rigs with Chevron.

  • Wireline segment

    Management described a Q2 rebound but expects reduced activity and more modest profitability in the back half of 2026.

Related articles

$MURMedAI 8/10

Murphy Oil Sees Sharp Profit Increase

Murphy Oil Corp reported Q2 2026 adjusted net income of $225.8 million, nearly six times Q2 2025, as higher oil prices offset lower production and weaker gas. Adjusted EPS was $1.55 vs $1.51 consensus. Revenue rose to $926.3 million. Murphy kept its $0.35 dividend and raised 2026 capex midpoint to $1.55 billion.

$GSBDMed

Goldman Sachs BDC Q2 Earnings Call Highlights

Goldman Sachs BDC (NYSE:GSBD) reported no incentive fee in Q2, citing its three-year total-return lookback provision. NAV was $12.06/share at June 30 vs $12.17 in Q1. The board declared a Q3 base dividend of $0.32/share plus $0.03 supplemental. Investments were $3.2B fair value, non-accrual 2.9%, and net debt-to-equity 1.35x.

$HBBMed

Hamilton Beach Brands Q2 Earnings Call Highlights

Hamilton Beach Brands (HBB) reported Q2 gross margin of 26.1% excluding tariff-related benefits, and said it expects 2026 revenue growth in the mid-single-digit range. Management forecast full-year gross margin to improve modestly and operating profit to decline by a high-single-digit percentage. Operating cash flow is expected at $35M to $45M. HBB ended with net cash of $51.5M.

$GXOMed

GXO Logistics Q2 Earnings Call Highlights

GXO Logistics reported Q2 results and said it secured over $1 billion in expected incremental new-business revenue for 2026 and about $353 million for 2027. Management cited a $2.7 billion sales pipeline after quarter end. Operating cash flow was $76 million, free cash flow positive $12 million, cash $769 million, and net leverage 2.6x. GXO plans to target EBIT margins above 6% and deploy AI across ~50 sites in 2026.

$GRNDMed

Grindr Q2 Earnings Call Highlights

Grindr (NYSE:GRND) said free users remain central to its strategy, while AI tools are boosting engineering productivity. Management estimated engineering output rose about 2.5x from July 2025 to April 2026 with similar headcount, supporting a 39% to 42% adjusted EBITDA margin outlook. EDGE AI premium tier rollout is planned for later in fall; operating expenses ex cost of revenue were $71M vs $53M.

$HAEMedAI 8/10

Haemonetics Q1 Earnings Call Highlights

Haemonetics (NYSE:HAE) reported Q1 interventional technologies returning to 3% organic growth, with vascular closure led by VASCADE MVP and MVP XL momentum in the U.S. Apheresis revenue rose 6% organically to $191M and plasma revenue grew 8% organically as Persona PLUS rollout accelerates. Haemonetics raised FY2027 revenue guidance to 5% to 8% reported and 4% to 7% organic.